A Newly Discovered Brain Circuit Explains Why Overeating Continues During Obesity
Scientists found a previously unknown set of NPY neurons in the brain's hunger center that keeps driving food intake during obesity by hijacking satiety neurons' response to leptin.
Quick Facts
What This Study Found
The researchers identified a previously unknown population of AgRP-negative NPY neurons in the arcuate nucleus of the hypothalamus. Under positive energy balance (high-fat diet or genetic obesity), NPY2 receptor expression increases specifically on POMC neurons — the cells that normally signal fullness.
This upregulation allows NPY released from the newly discovered AgRP-negative neurons to override POMC satiety signaling and alter leptin responsiveness. When the researchers artificially activated this circuit using chemogenetics, mice ate significantly more. When they inhibited it with optogenetics, feeding decreased. Mice lacking NPY2 receptors on their POMC neurons ate less and had lower body fat.
Key Numbers
NPY2R upregulated on POMC neurons during HFD; chemogenetic activation strongly drives feeding; optogenetic inhibition reduces feeding; Npy2r knockout on POMC neurons reduces food intake and fat mass
How They Did This
This was a mouse neuroscience study using multiple advanced techniques. The team fed mice a high-fat diet or used genetically obese mice lacking leptin receptors. They mapped neural circuits to identify AgRP-negative NPY neurons projecting to POMC neurons. They used chemogenetics (DREADDs) to activate the circuit and optogenetics to inhibit it, measuring food intake in both cases. They also created mice with NPY2 receptors genetically removed from POMC neurons to test the receptor's role in feeding and fat accumulation.
Why This Research Matters
Obesity research has long struggled to explain why the brain keeps promoting food intake even when the body clearly has excess energy stored as fat. This study reveals a specific neural mechanism: a subset of NPY neurons that bypasses normal satiety controls by targeting high-affinity receptors that remain responsive even when overall NPY levels drop. This circuit could be a future drug target for obesity treatment — blocking NPY2R on POMC neurons might help restore normal appetite regulation in people with obesity.
The Bigger Picture
This discovery adds an important piece to our understanding of hypothalamic appetite control — a field central to the GLP-1 drug revolution. While semaglutide and tirzepatide work through incretin pathways, NPY/POMC circuits represent a parallel hunger system. Understanding how obesity rewires these circuits at the receptor level could lead to complementary treatments that address the brain's appetite drive from a different angle, potentially improving outcomes for patients who don't respond fully to GLP-1 drugs alone.
What This Study Doesn't Tell Us
This is entirely a mouse study, and the specific neural circuits identified may not map identically to the human brain. The chemogenetic and optogenetic tools used provide artificial stimulation that may not perfectly mimic natural neural activity. The study focused on circuit identification and proof-of-concept rather than therapeutic development, and long-term metabolic outcomes were not detailed in the abstract.
Questions This Raises
- ?Do humans have an equivalent population of AgRP-negative NPY neurons, and does NPY2R upregulation on POMC neurons occur in human obesity?
- ?Could drugs targeting the NPY2 receptor on POMC neurons be developed as a complementary approach to GLP-1 agonists for obesity treatment?
- ?How does this NPY2R-mediated circuit interact with leptin resistance — does restoring leptin sensitivity in POMC neurons reverse the overeating drive?
Trust & Context
- Key Stat:
- New appetite circuit discovered AgRP-negative NPY neurons override satiety signaling by targeting NPY2 receptors on POMC neurons during energy surplus
- Evidence Grade:
- Rated 'strong' for preclinical research because the study used multiple complementary techniques (circuit mapping, chemogenetics, optogenetics, genetic knockout) all converging on the same conclusion, and was published in Cell Metabolism, a top-tier journal.
- Study Age:
- Published in 2023 in Cell Metabolism. This is recent research representing a novel circuit discovery that is likely still being followed up with additional studies.
- Original Title:
- Agrp-negative arcuate NPY neurons drive feeding under positive energy balance via altering leptin responsiveness in POMC neurons.
- Published In:
- Cell metabolism, 35(6), 979-995.e7 (2023)
- Authors:
- Qi, Yue, Lee, Nicola J, Ip, Chi Kin(2), Enriquez, Ronaldo, Tasan, Ramon, Zhang, Lei, Herzog, Herbert
- Database ID:
- RPEP-07294
Evidence Hierarchy
Frequently Asked Questions
What is NPY and why is it important for appetite?
Neuropeptide Y (NPY) is one of the most potent appetite-stimulating molecules in the brain. It's produced by neurons in the hypothalamus and signals the body to eat. This study found a new subtype of NPY neuron that keeps driving hunger even during obesity, when the body should be signaling fullness.
How does this relate to leptin resistance in obesity?
Leptin is a hormone that tells the brain you have enough fat stored and should stop eating. In obesity, the brain becomes resistant to leptin. This study shows one mechanism: NPY acting through NPY2 receptors on POMC neurons directly alters their ability to respond to leptin, helping explain why the 'stop eating' signal fails during obesity.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-07294APA
Qi, Yue; Lee, Nicola J; Ip, Chi Kin; Enriquez, Ronaldo; Tasan, Ramon; Zhang, Lei; Herzog, Herbert. (2023). Agrp-negative arcuate NPY neurons drive feeding under positive energy balance via altering leptin responsiveness in POMC neurons.. Cell metabolism, 35(6), 979-995.e7. https://doi.org/10.1016/j.cmet.2023.04.020
MLA
Qi, Yue, et al. "Agrp-negative arcuate NPY neurons drive feeding under positive energy balance via altering leptin responsiveness in POMC neurons.." Cell metabolism, 2023. https://doi.org/10.1016/j.cmet.2023.04.020
RethinkPeptides
RethinkPeptides Research Database. "Agrp-negative arcuate NPY neurons drive feeding under positi..." RPEP-07294. Retrieved from https://rethinkpeptides.com/research/qi-2023-agrpnegative-arcuate-npy-neurons
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.